Discovery of necrosis avidity of rhein and its applications in necrosis imaging-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Discovery of necrosis avidity of rhein and its applications in necrosis imaging

Published:2020-04-30 Issue:9 Volume:28 Page:904-912
ISSN:1061-186X
Container-title:Journal of Drug Targeting
language:en
Short-container-title:Journal of Drug Targeting

Author:

Zhang Dongjian¹²^ORCID,Jin Qiaomei¹²^ORCID,Ni Yicheng³^ORCID,Zhang Jian¹²^ORCID

Affiliation:

1. Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, P.R. China;

2. Laboratories of Translational Medicine, Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, P.R. China;

3. Theragnostic Laboratory, KU Leuven, Leuven, Belgium

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Link

https://www.tandfonline.com/doi/pdf/10.1080/1061186X.2020.1759079

Reference82 articles.

1. Updated developments on molecular imaging and therapeutic strategies directed against necrosis

2. Necrosis Avidity of Organic Compounds: A Natural Phenomenon with Exploitable Theragnostic Potentials

3. A New Method for Radionuclide Imaging of Myocardial Infarcts

4. Metalloporphyrins and Functional Analogues as MRI Contrast Agents

5. Necrosis Avid Contrast Agents

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Red/NIR‐I‐Fluorescence Carbon Dots Based on Rhein with Active Oxygen Scavenging and Colitis Targeting for UC Therapeutics;Advanced Healthcare Materials;2024-03-25

2. Dialog beyond the Grave: Necrosis in the Tumor Microenvironment and Its Contribution to Tumor Growth;International Journal of Molecular Sciences;2023-03-09

3. Future Prospective of Radiopharmaceuticals from Natural Compounds Using Iodine Radioisotopes as Theranostic Agents;Molecules;2022-11-18

4. Fundamental understanding of the size and surface modification effects on r₁, the relaxivity of Prussian blue nanocube@m-SiO₂: a novel targeted chemo-photodynamic theranostic agent to treat colon cancer;RSC Advances;2022

5. In Vivo Evaluation of Gallium-68-Labeled IRDye800CW as a Necrosis Avid Contrast Agent in Solid Tumors;Contrast Media & Molecular Imaging;2021-12-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3